Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raoul Bergner

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2005
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mgRaoul Bergner, Martin Hoffmann, Klaus-Dieter Riedel, et al.
International Journal of Molecular Sciences|July 24, 2021
CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney DiseaseZoran V Popovic, Felix Bestvater, Damir Krunic, et al.
Rheumatology International|November 22, 2020
Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysisClaudius Speer, Christine Altenmüller-Walther, Jan Splitthoff, et al.
Journal of Nephrology|March 16, 2026
Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteriaStefan Krämer, Kristian Vogt, Martin Busch, et al.
Rheumatology International|December 2, 2025
Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patternsKristian Vogt, Stefan Krämer, Teresa Maria Schreibing, et al.
Medicine|August 16, 2021
Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort studyClaudius Speer, Christine Altenmüller-Walther, Jan Splitthoff, et al.
RMD Open|December 19, 2023
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trialMichaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Rheumatology (Oxford, England)|September 17, 2020
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CAR.D.AKonstantinos Triantafyllias, Lorenzo Cavagna, Anna Klonowski, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 16, 2022
Management of Hepatic SarcoidosisJanina Sollors, Bernhard Schlevogt, Hartmut J Schmidt, et al.
Journal of Clinical Medicine|March 25, 2022
Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 TherapyMaximilian Töllner, Claudius Speer, Louise Benning, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2005
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mgRaoul Bergner, Martin Hoffmann, Klaus-Dieter Riedel, et al.
International Journal of Molecular Sciences|July 24, 2021
CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney DiseaseZoran V Popovic, Felix Bestvater, Damir Krunic, et al.
Rheumatology International|November 22, 2020
Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysisClaudius Speer, Christine Altenmüller-Walther, Jan Splitthoff, et al.
Journal of Nephrology|March 16, 2026
Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteriaStefan Krämer, Kristian Vogt, Martin Busch, et al.
Rheumatology International|December 2, 2025
Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patternsKristian Vogt, Stefan Krämer, Teresa Maria Schreibing, et al.
Medicine|August 16, 2021
Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort studyClaudius Speer, Christine Altenmüller-Walther, Jan Splitthoff, et al.
RMD Open|December 19, 2023
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trialMichaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Rheumatology (Oxford, England)|September 17, 2020
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CAR.D.AKonstantinos Triantafyllias, Lorenzo Cavagna, Anna Klonowski, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 16, 2022
Management of Hepatic SarcoidosisJanina Sollors, Bernhard Schlevogt, Hartmut J Schmidt, et al.
Journal of Clinical Medicine|March 25, 2022
Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 TherapyMaximilian Töllner, Claudius Speer, Louise Benning, et al.
Pageof 6